← Back to directory
QV
Qiming Venture Partners
Shanghai, ChinaWebsite ↗
Qiming Venture Partners is a leading China-based venture capital firm that invests in early and growth-stage companies across the technology and healthcare industries. The firm is recognized for its exceptional investment performance and its commitment to empowering entrepreneurs to transform innovative ideas into market leaders.
Last raised
Nov 2022
3y 8mo ago
Latest fund size
$2.5B
Qiming Venture Partners USD Fund VIII
AUM
$9.5B
estimated
Funds raised
Capital this firm has raised, newest first
Qiming Venture Partners USD Fund VIII
Nov 2022 · Fund VIII
$2.5B
Qiming Venture Partners RMB Fund VII
Nov 2022 · RMB Fund VII
$700M
Qiming Venture Partners RMB Fund VI
Jan 2021 · RMB Fund VI
$441.1M
Qiming Venture Partners Fund VII
Nov 2020 · Fund VII
$1.2B
Qiming Venture Partners Fund II
Jun 2008 · Fund II
$320M
Qiming Venture Partners Fund I
Jan 2006 · Fund I
$200M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| LTZ Therapeutics | — | — | May 2026 | |
| Aureka Biotechnologies | Series A | — | Apr 2026 | |
| OriCell Therapeutics | — | — | Apr 2026 | |
| Shengshu Technology | Series A | $8.6B | Apr 2026 | |
| QL Biopharma | Series C | $72.8M | Mar 2026 | |
| Tianhu Technology | Series A | — | Feb 2026 |
Sources
Where this data came from